Pivotal bioVenture Partners Fund I, L.P.

Other

US·SEC (Form 4)

Inozyme Pharma, Inc.

0

Total declarations

0

Company

€4m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Explore the complete record of transactions filed by Pivotal bioVenture Partners Fund I, L.P.. Officer active across 1 companies, notably Inozyme Pharma, Inc.. In total, 1 reports have been recorded. Total volume traded: €3.7m. The latest transaction was filed on 19 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Declarations1 total

Executives▲PurchaseIInozyme Pharma, Inc.41SEC

P

Pivotal bioVenture Partners Fund I, L.P.Director

€4m1,070,000 shares@ €3.4184100.0% of flow

Common Stock

SEC:0001062993-22-010574:0·19 Apr 2022

Ideal exit: 14 Jan 2023 (T+270)

SEC ↗

1 of 1 declaration